McNani says status room staff and members of Congress will initially have access to the vaccine

White House Press Secretary Kaylee McNani said Monday that staff in the White House status room and some members of Congress will have early access to the corona virus vaccine. President TrumpDonald Trump decides to change the name of the Cleveland baseball team: ‘Cancel culture at work’ Trump says White House staff should not be the first to get the corona virus vaccine in Michigan on Monday to close legislative office buildings due to ‘credible violent threats’. Stopped plans to offer some of the first levels to high-ranking employees.

“What the president has decided is that front line workers should come first. Those who live in long-term care facilities should come first,” McCanny told Fox News. “We still have a continuation of government. Key officials, such as circumstance room staff, may have access to the vaccine for some members of Congress. ”

The New York Times first reported Sunday that senior White House officials will be among the first to receive the dose of the corona virus vaccine. A National Security Council spokesman backed the plan, saying it was a continuation of government ethics enshrined in administrative policy.

However, Trump changed course late Sunday night, tweeting that White House officials should “get vaccinated a little later on this program, especially if it is not needed.”

“I have asked that this adjustment be made. I do not plan to be vaccinated, but I look forward to doing so at the right time, ”Trump tweeted. “Thanks!”

McCann’s comments make it clear which authorities will initially be considered needed to gain access to the vaccine. The White House Eco Room is a high security room in the basement of the White House that works with national security personnel at all times. It is unclear which vaccine members of Congress will receive the preferred dose.

The United States began vaccinating Americans against the corona virus novel on Monday, after states received the first export of a vaccine manufactured by Pfizer and BioNtech, approved for emergency use by the Food and Drug Administration (FDA) on Friday.

Meanwhile, COVID-19 cases are currently increasing by more than 200,000 daily in the United States, underscoring the continuing threat posed by the virus beyond the bright spot of vaccine news.